Craft

Ligand Pharmaceuticals

Stock Price

$115.5

2024-10-29

Market Capitalization

$2.1 B

2024-10-29

Revenue

$268.1 M

FY, 2025

Ligand Pharmaceuticals Summary

Company Summary

Overview
Ligand Pharmaceuticals is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. It employs research technologies such as antibody discovery technologies, ion channel discovery technology, Pseudomonas fluorescens protein expression technology, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals.
Type
Public
Status
Active
Founded
1987
HQ
Jupiter, FL, US | view all locations
Website
https://www.ligand.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • John Kozarich
  • Jason Aryeh
  • Matthew Korenberg

    Matthew Korenberg, President and Chief Operating Officer

  • Todd Davis, Chief Executive Officer, Director

    LocationsView all

    4 locations detected

    • Jupiter, FL HQ

      United States

      555 Heritage Drive, Suite 200

    • Boston, MA

      United States

      800 Boylston Street, Suite 710

    • Lawrence, KS

      United States

      2033 Becker Drive, Suite 310

    • San Diego, CA

      United States

      3911 Sorrento Valley Blvd, Suite 110

    Ligand Pharmaceuticals Financials

    Summary Financials

    Revenue (Q1, 2026)
    $51.7M
    Net income (Q1, 2026)
    ($13.3M)
    Cash (Q1, 2026)
    $115.1M
    EBIT (Q1, 2026)
    $17.4M
    Enterprise value
    $2.0B

    Footer menu